Article info

Download PDFPDF

Protocol
A randomised, controlled, double blind study to assess mechanistic effects of combination therapy of dapagliflozin with exenatide QW versus dapagliflozin alone in obese patients with type 2 diabetes mellitus (RESILIENT): study protocol

Authors

  • Emily Brown Metabolism and Nutrition Research Group, University Hospital Aintree, Liverpool University Hospitals NHS Foundation Trust, Liverpool, UKDepartment of Cardiovascular and Metabolic Medicine, Institute of Life Course and Medical Sciences, University of Liverpool, Liverpool, UK PubMed articlesGoogle scholar articles
  • Moon M Wilton Department of Psychology, Institute of Population Health, University of Liverpool, Liverpool, UK PubMed articlesGoogle scholar articles
  • Victoria S Sprung Research Institute for Sport & Exercise Sciences, Liverpool John Moores University, Liverpool, UK PubMed articlesGoogle scholar articles
  • Joanne A Harrold Department of Psychology, Institute of Population Health, University of Liverpool, Liverpool, UK PubMed articlesGoogle scholar articles
  • Jason C G Halford School of Psychology, University of Leeds, Leeds, UK PubMed articlesGoogle scholar articles
  • Andrej Stancak Department of Psychology, Institute of Population Health, University of Liverpool, Liverpool, UK PubMed articlesGoogle scholar articles
  • Malcolm Burgess Department of Cardiology, University Hospital Aintree, Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK PubMed articlesGoogle scholar articles
  • Elaine Howarth Liverpool Clinical Trials Centre, Institute of Population Health, University of Liverpool, Liverpool, Merseyside, UK PubMed articlesGoogle scholar articles
  • A Margot Umpleby Department of Nutritional Sciences, University of Surrey, Guildford, UK PubMed articlesGoogle scholar articles
  • Graham J Kemp Liverpool Magnetic Resonance Imaging Centre (LiMRIC), University of Liverpool, Liverpool, UKDepartment of Musculoskeletal and Ageing Science, Institute of Life Course and Medical Sciences, University of Liverpool, Liverpool, UK PubMed articlesGoogle scholar articles
  • John PH Wilding Metabolism and Nutrition Research Group, University Hospital Aintree, Liverpool University Hospitals NHS Foundation Trust, Liverpool, UKDepartment of Cardiovascular and Metabolic Medicine, Institute of Life Course and Medical Sciences, University of Liverpool, Liverpool, UK PubMed articlesGoogle scholar articles
  • Daniel J Cuthbertson Department of Cardiovascular and Metabolic Medicine, Institute of Life Course and Medical Sciences, University of Liverpool, Liverpool, UKDepartment of Psychology, Institute of Population Health, University of Liverpool, Liverpool, UK PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Emily Brown; c.e.brown{at}liverpool.ac.uk
View Full Text

Citation

Brown E, Wilton MM, Sprung VS, et al
A randomised, controlled, double blind study to assess mechanistic effects of combination therapy of dapagliflozin with exenatide QW versus dapagliflozin alone in obese patients with type 2 diabetes mellitus (RESILIENT): study protocol

Publication history

  • Received October 7, 2020
  • Accepted June 28, 2021
  • First published July 20, 2021.
Online issue publication 
July 20, 2021

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.